Bochengyuan Biomedicine Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$29.2M
- Investors
-
1
Bochengyuan Biomedicine General Information
Description
Provider of biopharmaceutical research and development services designed to support drug discovery, pharmaceutical innovation, and life sciences commercialization. The company offers biomedical technology research, pharmaceutical development services, technical consulting, and biotechnology innovation solutions, thereby enabling pharmaceutical companies and research institutions to accelerate the development and commercialization of healthcare products.
Contact Information
Website
www.bcypharm.com(Operating Subsidiary)
Corporate Office
- Unit 306, Building B2, Biomedical Industrial Park
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215000
- China
Corporate Office
- Unit 306, Building B2, Biomedical Industrial Park
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215000
- China
Bochengyuan Biomedicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 02-Mar-2023 | $29.2M | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | 20-Jul-2022 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 15-Jul-2019 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | 26-Jan-2017 | Completed | Generating Revenue | |||
| 1. Secondary Transaction - Private | 14-Aug-2015 | Completed | Generating Revenue |
Bochengyuan Biomedicine Signals
Bochengyuan Biomedicine Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioSciKin | Corporation | Minority | ||
| Suzhou Industrial Park Venture Capital Guidance Fund | Venture Capital | Minority | ||
| Suzhou Oriza Holdings Corporation | Asset Manager | Minority |
Bochengyuan Biomedicine FAQs
-
When was Bochengyuan Biomedicine founded?
Bochengyuan Biomedicine was founded in 2011.
-
Where is Bochengyuan Biomedicine headquartered?
Bochengyuan Biomedicine is headquartered in Suzhou, China.
-
What is the size of Bochengyuan Biomedicine?
Bochengyuan Biomedicine has 9 total employees.
-
What industry is Bochengyuan Biomedicine in?
Bochengyuan Biomedicine’s primary industry is Drug Discovery.
-
Is Bochengyuan Biomedicine a private or public company?
Bochengyuan Biomedicine is a Private company.
-
What is the current valuation of Bochengyuan Biomedicine?
The current valuation of Bochengyuan Biomedicine is .
-
What is Bochengyuan Biomedicine’s current revenue?
The current revenue for Bochengyuan Biomedicine is .
-
Who are Bochengyuan Biomedicine’s investors?
BioSciKin, Suzhou Industrial Park Venture Capital Guidance Fund, and Suzhou Oriza Holdings Corporation have invested in Bochengyuan Biomedicine.
-
When was Bochengyuan Biomedicine acquired?
Bochengyuan Biomedicine was acquired on 02-Mar-2023.
-
Who acquired Bochengyuan Biomedicine?
Bochengyuan Biomedicine was acquired by Taienkang Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process